SCHEMBL24848568

SCHEMBL24848568

Cc1nc(C)n2c3ccccc3n3c4ccccc4nc3c12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
MAPT P10636 4/20 0.57
POLB P06746 4/20 0.57
LMNA P02545 4/20 0.57
HSD17B10 Q99714 3/20 0.57
TP53 P04637 1/20 0.57
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
GAA P10253 2/20 0.45
ALDH1A1 P00352 5/20 0.44
HPGD P15428 4/20 0.44
TSHR P16473 1/20 0.44
PDE10A Q9Y233 3/20 0.43
ADORA2A P29274 1/20 0.42
PDE2A O00408 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9710434 0.75 KDM4E (0.48) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL24848593 0.74 KDM4E (0.46) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL24848565 0.73 MAPT (0.53) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL10513812 0.72 KDM4E (1.00) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL17466962 0.70 MAPT (0.53) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL24848566 0.69 MAPT (0.51) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL18057364 0.69 KDM4E (0.60) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL20821356 0.69 KDM4E (0.59) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL17993463 0.69 KDM4E (0.65) KDM4EMAPTPOLBLMNAHSD17B10
SCHEMBL19786607 0.67 TYMS (0.60) KDM4EMAPTPOLBLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230006153-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006153-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OTC KDM4E 1544/4885MAPT 1102/4885POLB 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.